An IL‐12‐Based Vaccine Approach for Preventing Immunopathology in Schistosomiasis
- 1 October 1996
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 795 (1) , 202-207
- https://doi.org/10.1111/j.1749-6632.1996.tb52669.x
Abstract
Click on the article title to read more.Keywords
This publication has 20 references indexed in Scilit:
- An IL-12-based vaccination method for preventing fibrosis induced by schistosome infectionNature, 1995
- Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology.The Journal of Experimental Medicine, 1994
- The Adjuvant Effect of Interleukin-12 in a Vaccine Against Leishmania majorScience, 1994
- Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming.Proceedings of the National Academy of Sciences, 1993
- Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.The Journal of Experimental Medicine, 1993
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993
- Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.The Journal of Experimental Medicine, 1992
- Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.The Journal of Experimental Medicine, 1991
- Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation.The Journal of Experimental Medicine, 1989
- In Vitro Granuloma Formation Using Defined Antigenic NidiaAnnals of the New York Academy of Sciences, 1986